Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online Conferences White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > ebr

PUBLICATIONS

European Biopharmaceutical Review

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique
position in scientific publishing. Published quarterly, it provides a dedicated platform
of communication and information for the European biopharmaceutical market across Europe, North America, and the rest of the world.

With editorial consisting of in-depth articles, case studies, meetings, and report
reviews written by specialists with hands-on experience in the biopharma industry; traditional multi-national pharma companies; investment houses; and industry-associated governmental, economic, and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical
research and development, with regular feature sections on BioBusiness
Development, Research and Innovation, BioDiscovery, BioManufacturing
plus special focusses on geographic or therapeutic territories.

For further information please contact:
Advertising David Hirsh	Editorial Rema Farhan

Connect with us on Twitter: follow @EBRmagazine

Read our publications on the go in the Samedan app for phones and tablets. You can download issues for offline reading, and our archives go as far back as 2008! Download for free on the App Store, GooglePlay, or Amazon.

Click here to view the digital version of EBR

	Subscribe
	Current Issue
	Archives
	Media Info
	Our Clients

Featured in this issue

Cell Therapy

Cell and Gene Therapy Development

Opportunities and Challenges in Cancer Innovations

Following some suggestions that almost all cancer treatments will eventually be based on cell and gene therapy approaches, Dr Ger Brophy at Avantor takes a step back to evaluate their progress and what is needed to reap their full potential.

ATMPs and Immunoncology

Q&A: The Growth of Advanced Therapy Medicinal Products

A New Class of Innovation

eXmoor Pharma Concepts’ Dr Angela Obsorne talks to EBR about the promise of advanced therapy medicinal products and the impact of Brexit on the UK's approach to these.

Discovery and Development Technology

Rewriting Drug Discovery and Development

The Authenticity of Synthetics

The impact of synthetic biology is forecast to be broad, as explained by Evonetix’s Dr Tim Brears who sheds light on its potential to empower drug discovery, with particular regard towards DNA sequencing.

Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd

Published quarterly in
January, April,
July, and October

Widgets Magazine

Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

All events >>

News and Press Releases

Turkish Cargo sponsored the carriage of historical artifacts from the Topkapı and Dolmabahçe Palaces to Japan

Turkish Cargo, the air cargo brand of Turkish Airlines that provides service to 124 countries, carried 186 historical artifacts, owned by Dolmabahçe and Topkapı Palaces, to Tokyo, the capital of Japan, as the sponsor carrier, in order to be displayed at the exhibition titled as "The Ottoman Empire and Tulip Culture" held as part of the events organized for 2019 which was declared as the "Year of Turkish Culture" across Japan.
More info >>

All releases >>

Air Transport Publications

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

All white papers >>